Supplementary Table 1.
Hits obtained from searching the RNA motifs in miRBase (v. 16) for overlap with our database of RNA motif-small molecule interactions using inforna. Only RNA motifs that are in processing sites (by Drosha or Dicer) of miRNAs associated with diseases are listed. The structures of the small molecules are shown in Fig. 1 
Supplementary Fig. 1 : Secondary structures of the hairpin cassette (C1) used to display the 3x3 nucleotide internal loop library (3x3 ILL) and RNA competitor oligonucleotides C2-C6. C7 and C8 were used to prevent non-specific interactions to DNA. pre$miR$525* pre$miR$661* 00* 0 0 * pre$miR$885* 00 * Probability* *99%** 99%*>*Probability* *95%** 95%*>*Probability* *90%* 90%*>*Probability* *80%* 80%*>*Probability* *70%* 70%*>*Probability* *60%* 60%*>*Probability* *50%* 50%*>*Probability* Supplementary Fig. 4 : A partition function calculation 12 was used to predict the base pairing probabilities for each miRNA target that has overlap with our database of RNA motif-small molecule interactions. Importantly, ~77% (17/22) of the putative binding sites for the small molecules predicted to bind by inforna are predicted with >90% confidence. Of the remaining six target sites, the loop nucleotides and 5' closing base pair of three are predicted with >90% confidence. A, the lowest free energy structured for miR-96 predicted by RNAstructure 12 , including the probability of base pairing as determined by a partition function calculation 29 ; B, representative autoradiogram of enzymatic mapping of GGG-pre-miR-96, which is in agreement with the predicted structure. Nuclease protection assays show that G6, U8, U9, and U10 of GGG-pre-microRNA-96 are protected from RNase III and T1 cleavage by 1. GGG-pre-microRNA-96 was radioactively labeled and incubated with RNase III in
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the presence of 0, 1, and 10 µM of 1 (indicated by the triangle). "L" indicates a hydrolysis ladder; "Control RNA" is untreated with nuclease or compound; "S1" indicates GGG-pre-microRNA-96 cleaved with S1 nuclease (cleaves single stranded regions; green triangles); "V1" indicates GGG-pre-miR-96 cleaved with V1 nuclease (cleaves double stranded regions; red triangles); and T1 indicates cleavage with T1 nuclease (cleaves singled stranded Gs). Circles indicate nucleotides that are protected from cleavage, within or adjacent to the internal loop predicted by inforna to bind 1. C, the binding site of 1 in GGG-pre-miR-96 was placed into the cassette (C1; Supplementary Fig. 1 ) used in 2DCS selections and its structure was mapped with enzymes. Importantly, the cleavage pattern and the extent of cleavage is similar whether the motif is display in pre-miR-96 or the cassette used for selection.
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Supplementary Fig. 7 : Compound 1 inhibits Drosha processing in vitro and in vivo. A, representative gel autoradiogram that shows compound 1 inhibits Drosha cleavage in vitro (left) and quantification of the data (right). B, 1 inhibits Drosha processing of pri-miR-96 in vivo. Cells were treated with 1 followed by extraction of total RNA, which was subjected to qRT-PCR. An increase in the amount of pri-miR-96 was observed with concomitant decreases in expression of pre-miR-96 and mature miR-96. "*" indicates p<0.05; "**" indicates p<0.01 as determined by a two-tailed student t-test (n≥3). Errors bars are the standard deviations in the measurements. Fig. 10 : Top, Structures of the compounds screened for inhibiting the biogenesis of miR-96 using a luciferase model system.
Bottom, results for each compound in the model luciferase assay. None of the compounds is able to increase luciferase production indicating that they do not inhibit miR-96 biogenesis. Error bars are the standard deviations in the measurements.
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Supplementary Fig. 11 : Fitness Plots for various compounds predicted to bind miRNA precursors. Left, StARTS analysis for compounds 1, 2, and 3 and all potential miRNA targets. In each case, the compound inhibits biogenesis of its predicted miRNA target (Fig. 2B) . Right, StARTS analysis for compounds 1, 2, and 4 and all potential miRNA targets. Only compound 1 is expected to bind the miR-96 precursor with high affinity and selectivity. Compounds 2 and 4 are not predicted to bind tightly to the miR-96 precursor. 
